| Date Filed | Type | Description |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| McDowell Caryn Gordon (Chief Legal & Adm. Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 125,000 options to buy
@ $13.39, valued at
$1.7M
|
|
| 12/15/2020 |
4
| McDowell Caryn Gordon (Chief Legal & Adm. Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 75,000 options to buy
@ $29.6, valued at
$2.2M
Granted 100,000 options to buy
@ $29.6, valued at
$3M
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| McDowell Caryn Gordon (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Acquired 1,000 shares
@ $11.0245, valued at
$11k
|
|
| 06/17/2019 |
4
| McDowell Caryn Gordon (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,383 shares
@ $10.86, valued at
$15k
|
|
| 01/25/2019 |
4
| McDowell Caryn Gordon (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 50,000 options to buy
@ $17.23, valued at
$861.5k
|
|
| 01/02/2019 |
4
| McDowell Caryn Gordon (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Acquired 818 shares
@ $17.1105, valued at
$14k
|
|
| 05/03/2018 |
4
| McDowell Caryn Gordon (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 16,000 shares
@ $0
Granted 110,000 options to buy
@ $28.3, valued at
$3.1M
|
|
| 05/03/2018 |
3
| McDowell Caryn Gordon (SVP, GC & Secretary) has filed a Form 3 on Revance Therapeutics, Inc. |
| 03/01/2018 |
4
| McDowell Caryn Gordon (GC & Chief Compliance Officer) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 20,000 shares
@ $0.001, valued at
$20
Paid exercise price by delivering 2,452 shares
@ $7.75, valued at
$19k
Granted 15,226 options to buy
@ $7.8, valued at
$118.8k
Granted 14,774 options to buy
@ $7.8, valued at
$115.2k
|
|
| 01/18/2018 |
4
| McDowell Caryn Gordon (GC & Chief Compliance Officer) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 77 shares
@ $9, valued at
$693
Sold 652 shares
@ $9, valued at
$5.9k
Sold 653 shares
@ $9, valued at
$5.9k
Sold 625 shares
@ $9, valued at
$5.6k
Exercised 625 options to buy
@ $6.37, valued at
$4k
Exercised 652 options to buy
@ $6.67, valued at
$4.3k
Exercised 653 options to buy
@ $6.67, valued at
$4.4k
Exercised 77 options to buy
@ $6.67, valued at
$513.6 |
|
| 11/06/2017 |
4
| McDowell Caryn Gordon (GC & Chief Compliance Officer) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 2,460 shares
@ $12.9, valued at
$31.7k
Sold 1,800 shares
@ $13, valued at
$23.4k
Exercised 625 options to buy
@ $6.37, valued at
$4k
Exercised 653 options to buy
@ $6.67, valued at
$4.4k
Exercised 77 options to buy
@ $6.67, valued at
$513.6 |
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |